Trials / Completed
CompletedNCT02881931
FuRST 2.0 Cognitive Pre-Testing
FuRST 2.0: Cognitive Pre-Testing Study for a New Functional Rating Scale for Use in Huntington's Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 75 (actual)
- Sponsor
- CHDI Foundation, Inc. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The FuRST 2.0 scale is being developed as a Patient Reported Outcome (PRO) with information coming directly from the Huntington's Disease Gene Expansion Carrier (HDGEC) and companion through self-report. The purpose of this study is to identify real or potential comprehension or usage problems with questionnaire items or response options. Through a process of structured cognitive de-briefing with HDGEC participants and companions, independently, followed by qualitative analysis, the final phrasing of the individual items and response options for the scale will be generated. Depending on the results of the first round of cognitive pre-testing, additional rounds of cognitive pre-testing may be required.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | FuRST 2.0 | Cognitive Pre-testing of new Functional Rating Scale |
Timeline
- Start date
- 2017-02-28
- Primary completion
- 2017-07-28
- Completion
- 2017-07-28
- First posted
- 2016-08-29
- Last updated
- 2017-08-08
Locations
4 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02881931. Inclusion in this directory is not an endorsement.